1. Home
  2. CRNC vs NPCE Comparison

CRNC vs NPCE Comparison

Compare CRNC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerence Inc.

CRNC

Cerence Inc.

HOLD

Current Price

$10.31

Market Cap

479.9M

Sector

Technology

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.30

Market Cap

536.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNC
NPCE
Founded
2020
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.9M
536.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CRNC
NPCE
Price
$10.31
$16.30
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$10.25
$18.33
AVG Volume (30 Days)
1.0M
168.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
96.95
29.03
EPS
N/A
N/A
Revenue
$251,781,000.00
$99,986,000.00
Revenue This Year
$27.18
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$5.85
$7.56
52 Week High
$13.74
$19.60

Technical Indicators

Market Signals
Indicator
CRNC
NPCE
Relative Strength Index (RSI) 48.41 53.76
Support Level $9.18 $15.25
Resistance Level $11.49 $16.96
Average True Range (ATR) 0.80 0.68
MACD -0.16 0.09
Stochastic Oscillator 43.41 60.34

Price Performance

Historical Comparison
CRNC
NPCE

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: